Title: MCM6 is a Poor Prognostic Biomarker and Promotes Progression in Breast Cancer
Authors: Zi Lei, Peng Wang, Da-qi Jia, Lei-lei Li, Yi-peng Wu, Yuan Yang, Guo-qing Pan, Taeg Kyu Kwon
Section: 3.6 MCM6 Knockdown Inhibited the Proliferation of Breast Cancer Cells
Andrlová H, Meiss F. Trametinib (GSK1120212). Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 2018; 211: 91–100. [40] Ascierto PA, Ferrucci PF, Fisher R, Del Vecchio M, Atkinson V, Schmidt H, et al. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Nature Medicine. 2019; 25: 941–946.